- A. Pain
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- U. Böhme
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- A. E. Berry
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- K. Mungall
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- R. D. Finn
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- A. P. Jackson
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- T. Mourier
(Ancient DNA and Evolution Group, University of Copenhagen)
- J. Mistry
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- E. M. Pasini
(Biomedical Primate Research Centre, PO Box 3306, 2280 GH, Rijswijk, The Netherlands)
- M. A. Aslett
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- S. Balasubrammaniam
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- K. Borgwardt
(Machine Learning Group, University of Cambridge, Trumpington Street, Cambridge CB2 1PZ, UK)
- K. Brooks
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- C. Carret
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- T. J. Carver
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- I. Cherevach
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- T. Chillingworth
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- T. G. Clark
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK
Wellcome Trust Centre for Human genetic, University of Oxford, Roosevelt Drive, Oxford OX3 9BN, UK)
- M. R. Galinski
(Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, 954 Gatewood Road, Atlanta, Georgia 30329, USA)
- N. Hall
(School of Biological Sciences, University of Liverpool, PO Box 147, Liverpool L69 3BX, UK)
- D. Harper
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- D. Harris
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- H. Hauser
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- A. Ivens
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- C. S. Janssen
(Institute of Biomedical and Life Sciences and Wellcome Centre for Molecular Parasitology, University of Glasgow, 120 University Place)
- T. Keane
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- N. Larke
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- S. Lapp
(Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, 954 Gatewood Road, Atlanta, Georgia 30329, USA)
- M. Marti
(Harvard School of Public Health, 677 Huntington Avenue, Boston, Massachusetts 02115, USA)
- S. Moule
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- I. M. Meyer
(2366 Main Mall, British Columbia, Vancouver V6T 1Z4, Canada)
- D. Ormond
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- N. Peters
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- M. Sanders
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- S. Sanders
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- T. J. Sargeant
(The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia
The University of Melbourne, Parkville, Victoria 3010, Australia)
- M. Simmonds
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- F. Smith
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- R. Squares
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- S. Thurston
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- A. R. Tivey
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- D. Walker
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- B. White
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- E. Zuiderwijk
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- C. Churcher
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- M. A. Quail
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- A. F. Cowman
(The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia)
- C. M. R. Turner
(Institute of Biomedical and Life Sciences and Wellcome Centre for Molecular Parasitology, University of Glasgow, 120 University Place)
- M. A. Rajandream
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- C. H. M. Kocken
(Biomedical Primate Research Centre, PO Box 3306, 2280 GH, Rijswijk, The Netherlands)
- A. W. Thomas
(Biomedical Primate Research Centre, PO Box 3306, 2280 GH, Rijswijk, The Netherlands)
- C. I. Newbold
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK
The Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK)
- B. G. Barrell
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)
- M. Berriman
(Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK)